Journal Publications (*co-first author, # corresponding author)
2024
86. Junde Wu, Huihui Fang,Jiayuan Zhu, Yu Zhang, Xiang Li, Yuanpei Liu, Huiying Liu, Yueming Jin, Weimin Huang, Qi Liu, Cen Chen, Yanfei Liu, Lixin Duan,Yanwu Xu#,Li Xiao#, Weihua Yang#,Yue Liu#. Multi-rater Prism: Learning self-calibrated medical image segmentation from multiple raters. Science Bulletin, 2024 (accepted)
85. Mengmeng Zhu*, Yiwen Li*, Wenting Wang, Yanfei Liu, Tiejun Tong, Yue Liu#. Development, validation and visualization of a web-based nomogram for predicting risk of new-onset diabetes after percutaneous coronary intervention. Sci Rep., 2024,14, 13652. https://doi.org/10.1038/s41598-024-64430-9
84. Li Y, Liu Y, Cui J, Zhu M, Wang W, Chen K, Huang L, Liu Y#. Oral-gut microbial transmission promotes diabetic coronary heart disease. Cardiovasc Diabetol. 2024, 23(1):123. doi: 10.11 86/s12933-024-02217-y. PMID: 38581039.
83. Yalan Dong, Zhenyu Kang, Zili Zhang, Yongqiang Zhang, Haifeng Zhou, Yanfei Liu, Xinxin Shuai, Junyi Li, Liangqingqing Yin, Xunxun Wang, Yan Ma, Heng Fan, Feng Jiang, Zhihao Lin, Congzhu Ding, Kim Yun Jin, Alexey Sarapultsev, Fangfei Li, Ge Zhang, Tian Xie, Changjun Yin, Xiang Cheng, Shanshan Luo#, Yue Liu#, Desheng Hu#. Single-cell profile reveals the landscape of cardiac immunity and identifies a cardio-protective Ym-1hi neutrophil in myocardial ischemia-reperfusion injury. Science Bulletin, 2024, https://doi.org/10.1016/j.scib.2024.02.003.
82. Wang W, Wang S, Li Y, Zhu M, Xu Q, Luo B, Liu Y#, Liu Y#. Network pharmacology, molecular docking, and in vitro experimental verification of the mechanism of Guanxining in treating diabetic atherosclerosis. J Ethnopharmacol. 2024, 28:117792. doi: 10.1016/j.jep.2024.117792.
81. Xu S, Liu Y, Wang Q, Liu F, Xian Y, Xu F#, Liu Y#. Gut microbiota in combination with blood metabolites reveals characteristics of the disease cluster of coronary artery disease and cognitive impairment: a Mendelian randomization study. Front. Immunol. 2024, 14:1308002. doi: 10.3389/fimmu.2023.1308002
2023年
80. Wang Q, Xu S, Liu F, Liu Y, Chen K, Huang L, Xu F#, Liu Y#. Causal relationship between sleep traits and cognitive impairment: A Mendelian randomization study. J Evid Based Med. 2023;16(4):485-494. doi: 10.1111/jebm.12576. PMID: 38108111.
79. Liu F, Liu Y, Xu S, Wang Q, Xu F, Liu Y#. Mendelian randomization study reveals a causal relationship between serum iron status and coronary heart disease and related cardiovascular diseases. Front Cardiovasc Med. 2023;10:1152201. doi: 10.3389/fcvm.2023.1152201. PMID: 37383700
78. Xu S*, Liu Y*, Wang Q, Liu F, Xu F, Liu Y#. Mendelian randomization study reveals a causal relationship between coronary artery disease and cognitive impairment. Front. Cardiovasc. Med. 2023, 10:1150432. doi: 10.3389/fcvm.2023.1150432
77. Yiwen Li*, Yanfei Liu*, Shiwei Liu*, Mengqi Gao, Wenting Wang, Keji Chen#, Luqi Huang#, Yue Liu#. Diabetic vascular diseases: Molecular mechanisms and therapeutic strategies[J]. Signal Transduction and Targeted Therapy, 2023,10;8(1):152.
76. Wenting Wang, Yanfei Liu, Yiwen Li, Binyu Luo, Zhixiu Lin, Keji Chen, Yue Liu#. Dietary patterns and cardiometabolic health: Clinical evidence and mechanism. MedComm. 2023; 4:e212. https://doi.org/10.1002/mco2.212
75. Yang X, Zhao X, Liu Y, Liu Y, Liu L, An Z, Xing H, Tian J, Song X. Ginkgo biloba extract protects against diabetic cardiomyopathy by restoring autophagy via adenosine monophosphate-activated protein kinase/mammalian target of the rapamycin pathway modulation. Phytother Res. 2023,37(4):1377-1390. doi: 10.1002/ptr.7746.
74. Wang Q, Xu S, Liu F, Liu Y, Liu Y# and Xu F. Development of risk prediction model for cognitive impairment in patients with coronary heart disease: A study protocol for a prospective, cross-sectional analysis. Front. Cardiovasc. Med. 2023, 9:1107544.
2022
73. Ziyu An , Jinfan Tian , Yue Liu , Xin Zhao , Xueyao Yang , Jingwen Yong , Libo Liu , Lijun Zhang , Wenjian Jiang , Xiantao Song , Hongjia Zhang. Exosomes as a Cell-free Therapy for Myocardial Injury Following Acute Myocardial Infarction or Ischemic Reperfusion. Aging and disease. 2022, 13(6): 1770-1786
72. Yiwen Li, Mengmeng Zhu, Yanfei Liu, Luo Binyu, Jing Cui, Luqi Huang, Keji Chen, Yue Liu#. The Oral Microbiota and Cardiometabolic Health: A Comprehensive Review and Emerging Insights. Frontiers in Immunology, 2022, 2022: 1010368. doi: 10.3389/fimmu.2022.1010368
71. Yanfei Liu, Hui Huang, Yu Sun , Yiwen Li , Bingyu Luo, Jing Cui , Mengmeng Zhu , Fukun Bi, Keji Chen, Yue Liu#. Monosodium Glutamate (MSG)-Induced mice model with unique diabetic retinal neuropathy features and artificial intelligence techniques for quantitative evaluation. Front. Immunol. 2022, 13:862702. doi: 10.3389/fimmu.2022.862702
70. Mengmeng Zhu, Yiwen Li, Binyu Luo, Jing Cui, Yanfei Liu#, Yue Liu#. Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease. Frontiers in Cardiovascular Medicine, 2022, 9:861110. doi: 10.3389/fcvm.2022.861110
69. Yanfei Liu, Hui Huang, Yiwen Li, Jing Cui, Tiejun Tong, Hongjun Yang#, Yue Liu#. Development of a method for quantitative evaluation of facial swelling in a rat model of cerebral ischemia by facial image processing. Frontier in Medicine, 2022, 9:737662.
68. Chengzhuo Li, Fengshuo Xu, Didi Han, Shuai Zheng, Wen Ma, Rui Yang, Zichen Wang, Yue Liu#, Jun Lyu#. Developing and verifying a multivariate model to predict the survival probability after coronary artery bypass grafting in patients with coronary atherosclerosis based on the MIMIC-III database. Heart & Lung, 2022, 52: 61-70.
2021年
67. Zhao X, Tian J, Liu Y, Ye Z, Xu M, Huang R, Song X. TLR4-Myd88 pathway upregulated caveolin-1 expression contributes to coronary artery spasm. Vascul Pharmacol. 2021:106947. doi: 10.1016/j.vph.2021.106947.
66. Xu F, Zhao F, Feng X, Li C, Han D, Zheng S, Liu Y#, Lyu J#. Nomogram for predicting cancer-specific survival in undifferentiated pleomorphic sarcoma: A Surveillance, Epidemiology, and End Results -based study. Cancer Control. 2021;28:10732748211036775. doi: 10.1177/10732748211036775.
65. Yiwen Li, Jing Cui, Yanfei Liu, Keji Chen, Luqi Huang, Yue Liu#. Development and validation of Risk prediction model for New-Onset Diabetes After Percutaneous Coronary Intervention (NODAP): a study protocol for a retrospective, multicenter analysis. Front. Cardiovasc. Med. 2021, 8:748256. doi: 10.3389/fcvm.2021.748256
64. Jia Liu*, Wei Yang*, Yue Liu*, Cheng Lv*, Lianguo Ruan*, Chen Zhao*, Ruili Huo*, Xin Shen*, Qing Miao*, Wenliang Lv*, Hao Li*, Huaxin Shi*, Lijie Hu*, Zhixu Yang*, Li Zhang*, Bing Wang*, Guoju Dong*, Yongyue Xian*, Bin Li*, Zhenqi Zhou*, Chunyan Xu*, Yingying Chen*, Yongjun Bian*, Jing Guo*, Jinliang Yang*, Jian Wang*, Wensheng Qi*, Suping Chen*, Yang Chen*, Bei Yan*, Wei Wang*, Jing Li*, Xiaolei Xie*, Ming Xu*, Jianxin Jiang*, Gang Wang*, Xiaodong Cong*, Haoning Zhu*, Jiaheng Shi*, Luxing Leng*, Dongxu Li*, Lanping Guo*, Luqi Huang#. Combination of Hua Shi Bai Du Granule (Q-14) and Standard Care in the Treatment of Patients with Coronavirus Disease 2019 (COVID-19): A Single-center, Open-label, Randomized Controlled Trial. Phytomedicine, 2021, 91:153761
63. Yiwen Li*, Jing Cui*, Yanfei Liu, Keji Chen, Luqi Huang, Yue Liu#. Oral, Tongue-coating microbiota and metabolic disorders: a novel area of interactive research. Front. Cardiovasc. Med. 2021,8:730203 https://doi.org/10.3389/fcvm.2021.730203
62. Xiao Li, Yajing Zhai, Jiaguo Zhao, Hairong He, Yuanjie Li, Yue Liu, Aozi Feng, Li Li, Tao Huang, Anding Xu, Jun Lyu. Impact of metabolic syndrome and it’s components on prognosis in patients with cardiovascular diseases: a meta-analysis. Frontiers in Cardiovascular Medicine, 2021,8:704145. https://doi.org/10.3389/fcvm.2021.704145
61. Li Y, Liu Y, Cui J, Zhao H, Liu Y# , Huang L#. Cohort Studies on Chronic Non-communicable Diseases Treated With Traditional Chinese Medicine: A Bibliometric Analysis.Front. Pharmacol. 2021;12:639860. doi: 10.3389/fphar.2021.639860
60. Chinese Association of Integrative Medicine; Chinese Medical Doctor Association; National Clinical Research Center for Chinese Medicine Cardiology; Cardiovascular Disease Working Group; Encephalopathy Disease Working Group; China Center for Evidence-Based Chinese Medicine, Chen KJ. Chinese Expert Consensus on Clinical Application of Oral Ginkgo biloba Preparations (2020). Chin J Integr Med. 2021;27(3):163-169. doi: 10.1007/s11655-021-3289-6. （第一执笔人）
59. Cui J, Liu Y, Li Y, Xu F#, Liu Y#. Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective. Front. Cardiovasc. Med. 2021, 8:644189. doi: 10.3389/fcvm.2021.644189
2020年
58. Yan Zhang, Biqing Wang,Chunxiao Ju,Lu Liu,Ying Zhu,Jun Mei,Yue Liu#, Fengqin Xu#.Traditional Chinese Medicine for Essential Hypertension: A Clinical Evidence Map[J].Evidence-Based Complementary and Alternative Medicine, 2020,2020:5471931. https://www.hindawi.com/journals/ecam/2020/5471931/
57. Liu Y, Echeverria V and Xu Y (2020) Editorial: Medicinal Plants for Cardiovascular and Neurodegenerative Aging-Related Diseases: From Bench to Bedside. Front. Pharmacol. 11:585155. https://doi.org/10.3389/fphar.2020.585155
56. Wen Yang, Yue Liu, Qing-Qing Xu, Yan-Fang Xian, Zhi-Xiu Lin. Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3β Pathway in Experimental Models of Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity, 2020,2020: 4754195. https://doi.org/10.1155/2020/4754195
55. Yan-Fang Xian, Chang Qu, Yue Liu, Siu-Po Ip, Qiu-Ju Yuan, Wen Yang, Zhi-Xiu Lin. Magnolol Ameliorates Behavioral Impairments and Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease. Oxid Med Cell Longev. 2020; 2020: 5920476. https://doi.org/10.1155/2020/5920476
54. Wang SZ, Lu YH, Wu M, Chen KJ, Liu Y, Liu LT. Cupping Therapy for Diseases: An Overview of Scientific Evidence from 2009 to 2019 [published online ahead of print, 2020 Jun 10]. Chin J Integr Med. 2020;doi: 10.1007/s11655-020-3060-y
53. Yanfei Liu*, Yue Liu*, Wantong Zhang, Mingyue Sun, Weiliang Weng, Rui Gao. Network pharmacology-based strategy to investigate the pharmacological mechanisms of Ginkgo biloba extract for aging. Evidence-Based Complementary and Alternative Medicine, 2020;2020: 8508491 https://doi.org/10.1155/2020/8508491
52. Zhao J, Lan X, Liu Y, Liu Y, Xian Y, Lin Z, Xu F. Anti-aging role of Chinese herbel medicine: an overview of scientific evidence from 2008 to 2018. Ann Palliat Med. 2020;9(3):1230-1248. doi: 10.21037/apm.2020.04.09.
51. Xie Q, Liu Y, Huang H, Hong B, Wang J, Han H#, Liu Y#. An Innovative Method for Screening and Evaluating the Degree of Diabetic Retinopathy and Drug Treatment Based on Artificial Intelligence Algorithms. Pharmacol Res. 2020;104986. doi:10.1016/j.phrs.2020.104986
50. Liu Y, Liu Y#. Herbal Medicine for Slowing Aging and Cardiovascular Risk:Mechanisms and Safety. Curr Vasc Pharmacol. 2020;18(4):305‐306. doi:10.2174/157016111804200507075606
49. Yanfei Liu, Hui Huang, Rui Gao, Yue Liu#. Dynamic Phenotypes and Molecular Mechanisms to Understand the Pathogenesis of Diabetic Nephropathy in Two Widely Used Animal Models of Type 2 Diabetes Mellitus. Front Cell Dev Biol. 2020;8:172. doi:10.3389/fcell.2020.00172
2019
48. Lan X, Zhao J, Zhang Y, Chen Y, Liu Y#, Xu F#. Oxymatrine exerts organ- and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis, and fibrosis: From bench to bedside. Pharmacol Res. 2019; 151:104541. doi:10.1016/j.phrs.2019.104541
47. Yanfei Liu, Weiliang Weng, Rui Gao#, Yue Liu#. New insights for Cellular and Molecular Mechanisms of Aging and Aging-related Diseases: Herbal Medicine as Potential Therapeutic Approach. Oxidative Medicine and Cellular Longevity. 2019, 2019: 4598167. DOI.org/10.1155/2019/4598167.
46. Lu W, Wang Q, Sun X, He H, Wang Q, Wu Y, Liu Y#, Wang Y# and Li C#. Qishen Granule Improved Cardiac Remodeling via Balancing M1 and M2 Macrophages. Front Pharmacol. 2019; 10:1399. doi:10.3389/fphar.2019.01399
45. Tian J, Popal MS, Zhao Y, Liu Y, Chen K, Liu Y#. Interplay between Exosomes and Autophagy in Cardiovascular Diseases: Novel Promising Target for Diagnostic and Therapeutic Application. Aging Dis. 2019; 10(6):1302–1310. doi:10.14336/AD.2018.1020
44. Yuerong Jiang, Haiyan Guo, Yue Liu, Xin Wang, Jiaqi Liang, Ruixi Xi, Ruina Bai, Dazhuo Shi. Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: Study protocol for a randomized controlled trial. Trials 12/2019; 20(1)., DOI:10.1186/s13063-019-3308-5
43. Jingen Li, Zhuye Gao, Lijing Zhang, Shengyao Li, Qiaoning Yang, Qinghua Shang, Xiang Gao, Hua Qu, Jie Gao, Lixiao Shi, Yue Liu, Jianpeng Du, Hao Xu, Dazhuo Shi: Qing-Xin-Jie-Yu Granule for patients with stable coronary artery disease (QUEST Trial): A multicenter, double-blinded, randomized trial. Complementary Therapies in Medicine 10/2019;, DOI:10.1016/j.ctim.2019.102209
42. Hui-Qin Li, Siu-Po Ip, Qiu-Ju Yuan, Guo-Qing Zheng, Karl KW Tsim, Tina TX Dong, Ge Lin, Yifan Han, Yue Liu, Yan-Fang Xian, Zhi-Xiu Lin: Isorhynchophylline Ameliorates Cognitive Impairment via Modulating Amyloid Pathology, Tau Hyperphosphorylation and Neuroinflammation: Studies in a Transgenic Mouse Model of Alzheimer’s Disease. Brain Behavior and Immunity, 2019; 82., DOI:10.1016/j.bbi.2019.08.194
41. Zhao JN, Zhang Y, Lan X, Chen Y, Li J, Zhang P, Wu LQ, Jia ST, Liu Y#, Xu FQ#. Efficacy and safety of Xinnaoning capsule in treating chronic stable angina (qi stagnation and blood stasis syndrome): Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial. Medicine (Baltimore). 2019; 98(31):e16539.
40. Jinfan Tian, Mohammad Sharif Popal, Yanfei Liu, Rui Gao, Shuzheng Lyu, Keji Chen, Yue Liu#: Ginkgo Biloba Leaf Extract Attenuates Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-/- Mice by Inhibiting Endoplasmic Reticulum Stress via Restoration of Autophagy through the mTOR Signaling Pathway. Oxidative Medicine and Cellular Longevity ,2019; 2019:8134678. DOI:10.1155/2019/8134678
39. Linqin Ma, Jingchun Zhang#, Yu Qiao, Xinli Sun, Ting Mao, Shuyan Lei, Qiaoxian Zheng, Yue Liu#: Intermittent Hypoxia Composite Abnormal Glucose Metabolism-Mediated Atherosclerosis In Vitro and In Vivo : The Role of SREBP-1. Oxidative Medicine and Cellular Longevity 2019; 2019:4862760. DOI:10.1155/2019/4862760
38. Yanfei Liu, Yinke Zhao, Jinfan Tian, Tiejun Tong, Rui Gao#, Yue Liu#: The association of depression following percutanous coronary intervention with adverse cardiovascular events Protocol for a systematic review and meta-analysis. Medicine,2019; 2019(98):2., DOI:10.1097/MD.0000000000013952
37. Song-zi Wang, Min Wu, Ke-ji Chen, Yue Liu, Jing Sun, Zhuo Sun, He Ma, Long-tao Liu: Hawthorn Extract Alleviates Atherosclerosis through Regulating Inflammation and Apoptosis Related Factors: An Experimental Study. Chinese Journal of Integrative Medicine 2019;25(2):108-115. doi: 10.1007/s11655-018-3020-4.
36. Mingwei Dai, Xiang Wan, Hao Peng, Yao Wang, Yue Liu, Jin Liu, Zongben Xu, Can Yang: Joint Analysis of Individual-level and Summary-level GWAS Data by Leveraging Pleiotropy. Bioinformatics ,2019;35(10):1729-1736. doi: 10.1093/bioinformatics/bty870.
2018
35. Yingke Zhao, Yee-Man Yu, Yanfei Liu, Tiejun Tong, Yue Liu#: Weight reduction and cardiovascular benefits Protocol for a systematic review and meta-analysis. Medicine,2018,97(50):e13246., DOI:10.1097/MD.0000000000013246
34. Mingyue Sun, Lulu Chai, Fang Lu, Yang Zhao, Qingna Li, Boya Cui, Rui Gao#, Yue Liu#: Efficacy and Safety of Ginkgo Biloba Pills for Coronary Heart Disease with Impaired Glucose Regulation: Study Protocol for a Series of N -of-1 Randomized, Double-Blind, Placebo-Controlled Trials. Evidence-based Complementary and Alternative Medicine , 2018; 2018(128):1-8., DOI:10.1155/2018/7571629
33. Hang-kun Ma, Yue Liu, Bo Li, Ying Zhang, Lin-juan Sun, Feng-qin Xu: Chinese Medicine for Alzheimer′s Disease: A Meta-Analysis of Randomized Controlled Trials. Chinese Journal of Integrative Medicine, 2018; 24(12)., DOI:10.1007/s11655-018-2567-4
32. Yu Qiao, Jingchun Zhang#, Yue Liu#, Zhiqi Liang, Yuhua Wang, Wei Zheng, Dazhuo Shi: Efficacy and Safety of Zhenyuan Capsule for Coronary Heart Disease with Abnormal Glucose and Lipid Metabolism: Study Protocol for a Randomized, Double-Blind, Parallel-Controlled, Multicenter Clinical Trial. Evidence-based Complementary and Alternative Medicine,2018,2018(5):1-7., DOI:10.1155/2018/1716430
31. Jinfan Tian, Yanfei Liu, Yue Liu#, Keji Chen, Shuzheng Lyu#: Ginkgo biloba Leaf Extract Protects against Myocardial Injury via Attenuation of Endoplasmic Reticulum Stress in Streptozotocin-Induced Diabetic ApoE −/− Mice. Oxidative Medicine and Cellular Longevity , 2018; 2018(9):1-13., DOI:10.1155/2018/2370617
2017
30. YingkeZhao, Yue Liu#: A mechanistic overview of Herbal Medicine and Botanical Compounds to Target Transcriptional Factors in Breast Cancer. Pharmacological Research,2018,130:292-302. doi: 10.1016/j.phrs.2017.12.027.
29. Jinfan Tian, Yue Liu*, Yanfei Liu, Xiantao Song, Min Zhang, Feng Xu, Fei Yuan, Shuzheng Lyu#: Prognostic Association of Circulating Neutrophil Count with No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction following Successful Primary Percutaneous Intervention. Disease markers , 2017; 2017(1):1-9., DOI:10.1155/2017/8458492
28. Jinfan Tian, Yingke Zhao, Yanfei Liu, Yue Liu#, Keji Chen, Shuzheng Lyu#: Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective. Oxidative Medicine and Cellular Longevity 10/2017; 2017(3):1-15., DOI:10.1155/2017/8214541
27. Yanfei Liu, Yue Liu#: Editorial: Vascular Protection of Herbal Medicine: Roles and Mechanisms. Current Vascular Pharmacology, 2017; 15(6)., DOI:10.2174/157016111506170928164646
26. Yanfei Liu, Mingyue Sun, Hezhi Yao, Yue Liu#, Rui Gao#: Herbal Medicine for the Treatment of Obesity: An Overview of Scientific Evidence from 2007 to 2017. Evidence-based Complementary and Alternative Medicine, 2017; 2017(3):1-17., DOI:10.1155/2017/8943059
25. Jinfan Tian, Yanfei Liu, Yue Liu#, Keji Chen, Shuzheng Lyu#: Cellular and Molecular Mechanisms of Diabetic Atherosclerosis: Herbal Medicines as a Potential Therapeutic Approach. Oxidative Medicine and Cellular Longevity , 2017; 2017(6):1-16., DOI:10.1155/2017/9080869
24. Jinfan Tian, Yue Liu#, Keji Chen: Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications. Current Vascular Pharmacology, 2017;15(6):532-548. doi: 10.2174/1570161115666170713095545.
23. Yingke Zhao, Branda Yee-Man Yu, Yanfei Liu, Yue Liu#: Meta-Analysis of the Effect of Obstructive Sleep Apnea on Cardiovascular Events After Percutaneous Coronary Intervention. The American journal of Cardiology ,2017,120(6):1026-1030. doi: 10.1016/j.amjcard.2017.06.035.
22. Long Cheng, Junmei Song, Geng Li, Yue Liu, Yuming Wang, Xiangbao Meng, Guibo Sun, Xiaobo Sun: Effects of the Tangningtongluo formula as an alternative strategy for diabetics via upregulation of insulin receptor substrate-1. Molecular Medicine Reports 06/2017; 16(1)., DOI:10.3892/mmr.2017.6679
21. Long Cheng, Yue Liu*, Xiao-bo Sun: The Clinical Efficacy of Yindanxinnaotong Soft Capsule in the Treatment of Stroke and Angina Pectoris: A Meta-Analysis. Evidence-based Complementary and Alternative Medicine ,2017; 2017(6):1-14. DOI:10.1155/2017/2060549
2016
20. Yingke Zhao, Yue liu#, Ke-ji Chen: Mechanisms and Clinical Application of Tetramethylpyrazine (an Interesting Natural Compound Isolated from Ligusticum Wallichii): Current Status and Perspective. Oxidative Medicine and Cellular Longevity , 2016; 2016:2124638., DOI:10.1155/2016/2124638
19. Yuanyuan Cui, Yue Liu*, Fuhai Zhao, Dazhuo Shi, Keji Chen: Neoatherosclerosis after Drug-Eluting Stent Implantation: Roles and Mechanisms. Oxidative Medicine and Cellular Longevity, 2016; 2016:5924234., DOI:10.1155/2016/5924234
18. Ming Guo, Yue Liu#, Da-zhuo Shi: Cardiovascular Actions and Therapeutic Potential of Tetramethylpyrazine (Active Component Isolated from Rhizoma Chuanxiong): Roles and Mechanisms. BioMed Research International, 2016; 2016:2430329., DOI:10.1155/2016/2430329
17. Yingying Sun, Yue Liu#, Keji Chen: Roles and mechanisms of ginsenoside in cardiovascular diseases:progress and perspectives. Science China. Life Sciences, 2016;59(3):292-298. doi: 10.1007/s11427-016-5007-8.
16. Jinfan Tian, Yue Liu*, Xiantao Song, Min Zhang, Feng Xu, Fei Yuan, Shuzheng Lyu: Clinic Predictive Factors for Insufficient Myocardial Reperfusion in ST-Segment Elevation Myocardial Infarction Patients Treated with Selective Aspiration Thrombectomy during Primary Percutaneous Coronary Intervention. BioMed Research International , 2016; 2016:1-9., DOI:10.1155/2016/3823809
15. Linqin Ma, Jingchun Zhang#, Yue Liu#: Roles and Mechanisms of Obstructive Sleep Apnea-Hypopnea Syndrome and Chronic Intermittent Hypoxia in Atherosclerosis: Evidence and Prospective. Oxidative Medicine and Cellular Longevity , 2016; 2016(5):1-10., DOI:10.1155/2016/8215082
2015
14. Baojun wang, Yue Liu*, qinghua shang, qingxiang zhang, lei zhang, jiangang liu, dazhuo shi: Interaction of Panax quinquefolius Saponin and Dual Antiplatelets on Vascular Endothelial Function in Rats with Acute Myocardial Infarction. BioMed Research International, 2015; 2015:932751, DOI:10.1155/2015/932751
2014
13. Long cheng, xiangbao meng, shan lu, tingting wang, yue liu, guibo sun, xiaobo sun: Evaluation of Hypoglycemic Efficacy of Tangningtongluo Formula, a Traditional Chinese Miao Medicine, in Two Rodent Animal Models. Journal of Diabetes Research ,2014;2014:745419. doi: 10.1155/2014/745419.
12. Chunxiao Wu, Jingchun Zhang, Yingke Zhao, Jing Chen, Yue Liu#: Chinese Herbal Medicine Bushen Qinggan Formula for Blood Pressure Variability and Endothelial Injury in Hypertensive Patients: A Randomized Controlled Pilot Clinical Trial. Evidence-based Complementary and Alternative Medicine, 2014; 2014:804171. DOI:10.1155/2014/804171
11. Yue Liu, Yuerong Jiang, Jingchun Zhang, Dazhuo Shi: Integrative Chinese and Western Medicine on Atherosclerosis of Coronary Heart Disease: What are the new control strategies?. Science Bulletin, 2014; 59(11):1091-1096., DOI:10.1007/s11434-014-0114-z
10. Ming Guo, Yue Liu*, Zhu-Ye Gao, Da-Zhuo Shi: Chinese Herbal Medicine on Dyslipidemia: Progress and Perspective. Evidence-based Complementary and Alternative Medicine, 2014; 2014(1):163036., DOI:10.1155/2014/163036
2013
9. Yue Liu, Huijun Yin, Keji Chen: Platelet proteomics and its advanced application for research of blood stasis syndrome and activated blood circulation herbs of Chinese medicine. Science China. Life sciences,2013; 56(11):1000-1006. DOI:10.1007/s11427-013-4551-8
8. Yue Liu, Huijun Yin, Yuerong Jiang, Mei Xue, Chunyu Guo, Dazhuo Shi, Keji Chen: Correlation between Platelet Gelsolin and Platelet Activation Level in Acute Myocardial Infarction Rats and Intervention Effect of Effective Components of Chuanxiong Rhizome and Red Peony Root. Evidence-based Complementary and Alternative Medicine, 2013; 2013:985746., DOI:10.1155/2013/985746
7. Chun-Xiao Wu, Yue Liu, Jing-Chun Zhang: Chronic intermittent hypoxia and hypertension: A review of systemic inflammation and Chinese Medicine. Chinese Journal of Integrative Medicine, 2013; 19(5):394-400., DOI:10.1007/s11655-013-1459-x
2012
6. Yue Liu, Hui-Jun Yin, Da-Zhuo Shi, Ke-Ji Chen: Chinese Herb and Formulas for Promoting Blood Circulation and Removing Blood Stasis and Antiplatelet Therapies. Evidence-based Complementary and Alternative Medicine,2012; 2012:184503., DOI:10.1155/2012/184503
5. Ke-Ji Chen, Yuan-Hua Xie, Yue Liu: Profiles of traditional Chinese medicine schools. Chinese Journal of Integrative Medicine, 2012; 18(7):534-538., DOI:10.1007/s11655-012-1147-2
4. Yue Liu, Ke-Ji Chen: Atherosclerosis, Vascular Aging and Therapeutic Strategies. Chinese Journal of Integrative Medicine 02/2012; 18(2):83-7., DOI:10.1007/s11655-012-0996-z
3. Yue Liu, HuiJun Yin, YueRong Jiang, Mei Xue, KeJi Chen: Correlation between platelet gelsolin level and different types of coronary heart disease. Science Bulletin, 2012, 57(6):631-638. DOI:10.1007/s11434-011-4926-9
2011
2. Yue Liu, Hui-jun Yin, Ke-ji Chen: Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease. Chinese Journal of Integrative Medicine, 2011; 17(8):587-92., DOI:10.1007/s11655-011-0814-z
1. Weimin Wang, Jingchun Zhang, Cong Cao, Tao Hou, Yue Liu, Keji Chen: An efficient approach to representing and mining knowledge from Qing court medical records. Frontiers of Computer Science in China , 2011; 5(4):395-404., DOI:10.1007/s11704-011-1021-y
中文文章目录(*通讯作者，#共同第一作者)：
2024
81.徐茜，王文婷，李逸雯，崔京，朱梦梦，刘艳飞*，刘玥*. 基于“心-脾-肠”轴探讨肠道菌群紊乱与代谢性心血管病的关系[J/OL].中国实验方剂学杂志,1-8[2024-07-13].https://doi.org/10.13422/j.cnki.syfjx.20241065.
80.王子钰,王文婷,徐仕晗，刘艳飞*，刘玥*.“异病同治”视角下从血瘀论治糖尿病视网膜病变与冠心病的现代机制探析[J].中国实验方剂学杂志，2024，30(05):197-205.
79.崔京, 李逸雯, 刘艳飞, 刘玥*. 干扰素诱导蛋白16的生物学机制研究进展[J].中国药理学通报，2024,40(2): 219-224
2023
78.罗斌玉, 徐仕晗, 李逸雯, 王文婷, 刘艳飞, 黄璐琦*, 刘玥*. 阻塞性睡眠呼吸暂停与心血管疾病的因果关系：一项两样本孟德尔随机化研究. 中国循证医学杂志, 2023, 23(10): 1137-1142.
77.鞠春晓，李逸雯，赵俊男，翁家俊，梅俊，王碧晴，刘玥*，徐凤芹*.中药治疗慢性心力衰竭用药规律及可能机制的研究[J].中药新药与临床药理,2023,34(09):1307-1316.
76.朱梦梦,王文婷,李逸雯，刘玥*.心脏术后新发糖尿病的危险因素：进展与思考[J].医学新知,2023,33(04):273-279.
75. 罗斌玉, 朱梦梦, 李逸雯, 崔京, 刘艳飞, 黄璐琦*, 刘玥*. 冠心病与阻塞性睡眠呼吸暂停综合征：基于中医“心肺同治”的解读与思考[J]. 中国实验方剂学杂志, 2023,29(20):198-204.
74.王文婷，刘艳飞，李逸雯，陈可冀，刘 玥*. 基于“瘀－毒－虚”探讨糖尿病血管钙化的发病机制及中医药防治策略[J]. 中国实验方剂学杂志，2023，29（18）：183-189.
73. 王文婷,刘艳飞,陈可冀,刘 玥*. 饮食模式防治代谢性心血管病：基于中医药理论的解读与思考[J]. 中国实验方剂学杂志,2023，29（19）：220-227
72. 崔京, 李逸雯, 罗斌玉, 王文婷, 朱梦梦, 王子钰, 刘艳飞, 陈可冀, 刘 玥*. 糖尿病泛血管病变：理念、现状与挑战. 中国循证医学杂志, 2023, 23(2): 133-138. doi: 10.7507/1672-2531.202209124
71. 蓝旭，张艳，赵俊男，陈瑶，刘 玥，徐凤芹.定性访谈在名老中医医案隐性知识挖掘中的应用探讨[J]. 北京中医药，2023,42（1）:59-62
2022
70.王青，刘艳飞，徐仕晗，刘凤岚，刘 玥*，徐凤芹*. 心脑同治及其中药转化研究：历史、现状与思考[J]. 中国实验方剂学杂志,2022,28（21）：171-178
69.王青, 刘凤岚, 徐仕晗, 刘艳飞, 刘玥*, 徐凤芹*. 冠心病继发认知障碍的动物模型研究进展[J]. 医学新知, 2022, 32(4): 260-269.
68.徐仕晗，刘艳飞，刘凤岚，王青，刘 玥*，徐凤芹*. 基于“异病同治”探讨活血解毒治疗冠心病和认知功能障碍的机制. 中国实验方剂学杂志，2022，28（21）：185-191
67.刘凤岚,朱梦梦,王青,徐仕晗,刘艳飞,刘 玥*,徐凤芹*. 心血管病继发认知障碍与心脑同治的中医药防治策略[J]. 中国实验方剂学杂志, 2022，28（21）：179-184
66.崔京，李逸雯，罗斌玉，朱梦梦，陈可冀，刘 玥*. 基于网络药理学和分子对接技术探讨活血解毒中药配伍抗动脉粥样硬化作用机制.中国药理学通报，2022，38（8）：1231-1238
65. 朱梦梦, 李逸雯, 罗斌玉, 崔京, 唐志书*, 刘 玥*. 中医药研究生国际期刊论文写作与发表现状调查. 中国循证医学杂志, 2022, 22(6): 634-640. doi: 10.7507/1672-2531.202201166
64. 朱梦梦,李逸雯,刘艳飞,崔京,罗斌玉,刘玥*,陈可冀*.因郁致瘀与冠心病[J].中国实验方剂学杂志,2022,28(9):176-182
63. 李逸雯，罗斌玉，崔京，朱梦梦，刘 玥*，徐浩，史大卓，陈可冀*.病证结合与冠心病防治策略[J].中国科学：生命科学，2022，52（6）：797-811
62. 刘艳飞，高蕊，徐凤芹，刘 玥*.血管衰老相关细胞模型的研究进展[J].中国病理生理学杂志，2022，38（3）：572-576.
61. 乔羽,张京春,刘 玥,马林沁,毛婷,孙欣丽.人参-川芎有效成分通过PPARγ/PGC-1α/UCP1通路调控白色脂肪棕色化的机制研究[J].中草药，2022，53(2):478-483.
60. 崔京，李逸雯，刘 玥*，陈可冀. 因瘀致衰与血管衰老. 中国中西医结合杂志，2022,42（4）：487-491
2021
59. 鞠春晓，张瑶，刘晓林，李逸雯，刘璐，王碧晴，梅俊，赵俊男，黄璐琦，刘 玥*，徐凤芹*. 慢性心力衰竭防治指南方法学质量评价. 中国循证医学杂志，2021，21（9）:1091-1097
58. 鞠春晓，张瑶，施玥，程百如，贾子君，王碧晴，张艳，刘璐，赵俊男，梅俊，刘 玥*，徐凤芹*. 心力衰竭中医药防治临床研究证据图. 中国循证医学杂志，2021，21（8）:964-972
57. 李逸雯#，刘 玥#，吕诚，杨洪军，陈可冀*，黄璐琦*.新型冠状病毒肺炎的中医药临床研究:基于文献计量学分析的解读与思考.科学通报，2021，66（26）:3385-3394 （封面文章）
56. 李逸雯，刘艳飞，崔京，黄璐琦，陈可冀，刘 玥*.冠心病中医药诊疗指南的方法学质量评价.中国循证医学杂志，2021，21（6）:696-702
2020
55. 刘 玥,杨华,刘龙涛,付长庚，陈可冀.口服银杏叶制剂临床应用中国专家共识(2020)[J].中国中西医结合杂志,2020,40(12):1424-1429.
54. 张京春,刘 玥,雷舒雁,毛婷,李海霞,王智先,杜武勋,李军,张伯礼,史大卓.振源胶囊治疗气阴两虚证稳定型心绞痛合并糖脂代谢异常的多中心、随机、双盲、安慰剂平行对照临床研究[J].中医杂志，2020,61(06):502-508.
53. 刘 玥,殷惠军,陈可冀.芍药苷联合川芎嗪对肌动蛋白微丝诱导血小板活化及血小板凝溶胶蛋白水平的干预效应研究[J].中国中西医结合杂志,2020，40(03):313-317.
52. 王哲,王娅,刘艳飞,刘玥*,李立志*.中药治疗心房颤动的系统评价再评价[J].中国循证医学杂志,2020,20(02):199-206.
2019
51. 王哲,刘艳飞,王娅,李立志,刘 玥*.缓慢性心律失常动物模型的研究进展[J].实用心电学杂志, 2019,28(06):447-450
50. 王娅,刘艳飞,王哲,刘 玥*,李立志*. 2015～2019 年中药治疗原发性高血压的系统评价再评价[J]. 中国循证医学杂志, 2019, 19(12): 1460-1469.
49. 马林沁,张京春*,刘 玥*,乔羽,毛婷,雷舒雁,郑乔仙,孙欣丽.益气活血中药配伍对间歇性低氧复合胰岛素抵抗细胞模型SREBP-1c/FAS信号通路的干预效应[J].世界科学技术-中医药现代化,2019,21(11):2516-2525.
48. 毛婷,张京春*,刘 玥*,乔羽,孙欣丽,刘蓓.阻塞性睡眠呼吸暂停低通气综合征对冠心病患者房颤风险影响的系统评价[J].中国循证医学杂志,2019,19(04):404-411.
47. 蓝旭,赵俊男,张颖,刘 玥*,徐凤芹*.隐性知识在中医药学术传承中的应用现状与思考[J].世界科学技术-中医药现代化,2019,21(03):361-365.
46. 梁芳，刘 玥*,田晋帆,田锐,梁家祺,吕树铮,史大卓.血小板凝溶胶蛋白及血瘀证计分与急性冠脉综合征患者临床预后的相关性研究[J].中国中西医结合杂志，2019，39(04):423-427.
45. 马林沁，张京春*，刘 玥*，乔羽，孙欣丽，雷舒雁，郑乔仙,毛婷.益气活血中药配伍对慢性间歇性低氧复合胰岛素抵抗介导的动脉粥样硬化动物模型的干预效应[J].中国中药杂志，2019，44(01):141-149.
2018
44. 刘 玥，高铸烨，付长庚，徐浩，史大卓，陈可冀.活血化瘀药物防治冠心病:循证与展望[J].中国循证医学杂志,2018，18(11):1145-1150.
43. 赵俊男，刘 玥*,张颖,张萍,王海云,李婧,童文新,徐凤芹*.中西医结合老年医学研究的进展与思考[J].中国循证医学杂志，2018，18(11):1191-1197.
42. 邬春晓，张京春*，刘 玥*，马林沁，乔羽，毛婷，雷舒雁，郑乔仙.间歇性低氧诱导人脐静脉内皮细胞损伤机制研究[J].医学研究杂志，2018，47(11):23-28.
41. 潘国凤，成龙*，刘 玥*，冯兴中.养阴清肺汤和养阴清肺口服液治疗慢性咽炎的Meta分析[J].中华中医药杂志,2018,33(06):2360-2363.
40. 刘艳飞，程冰丽，刘 玥*，陈可冀.活血化瘀方药延缓衰老的研究进展[J].医学研究杂志,2018,47(05):188-191.
39. 梁芳，王翔云，柴华，刘 玥*，史大卓.急性冠脉综合征患者临床预后影响因素的研究进展[J].医学研究杂志,2018,47(02):177-180.
2017
38. 刘艳飞，孙明月，赵莹科，姚贺之，刘 玥*，高蕊*.网络药理学在中药药物重定位研究中的应用现状与思考[J].中国循证医学杂志,2017,17(11):1344-1349.
37. 邬春晓,张京春*,刘 玥*,马林沁,乔羽,雷舒雁,郑乔仙.补肾清肝中药配伍对间歇性低氧诱导人脐静脉内皮细胞损伤模型p38MAPK/NF-κB信号通路的干预效应研究[J].中国中药杂志,2017,42(23):4661-4664.
36. 刘 玥,刘艳飞,田晋帆,付长庚,陈可冀.银杏叶提取物预处理对2型糖尿病大鼠心肌梗死后心血管保护效应研究[J].中国中西医结合杂志,2017,37(09):1100-1104.
35. 汪杰,张斌,赵永燕,熊恩来，刘 玥*.右心室流出道间隔部起搏的可行性及有效性分析[J].医学研究杂志,2017,46(07):44-47.
34. 刘艳飞,刘 玥*,成龙,王辉*.养阴清肺汤治疗慢性咳嗽和慢性阻塞性肺疾病疗效和安全性的Meta分析[J].中国循证医学杂志,2017,17(06):698-704.
33. 王欣,刘 玥*,成龙,董宇*.银丹心脑通软胶囊治疗心脑血管疾病临床疗效的Meta分析[J].中国循证医学杂志,2017,17(04):429-439.
32. 田晋帆,刘 玥*,李立志*,吕树铮.内质网应激与自噬及其交互效应:动脉粥样硬化潜在的治疗新靶标[J].生命科学,2017,29(04):356-363.
2016
31. 刘 玥, 陈可冀. 抑郁、焦虑状态与血栓形成：研究现状与思考 [J] .中华内科杂志,2016,55( 9 ): 670-672.
30. 马林沁,张京春*, 刘 玥*,张惠.中药人参制剂对胰岛素抵抗干预效应的Meta分析[J].中国循证医学杂志,2016,16(07):819-827.
29. 孙莹莹，刘 玥*,陈可冀.人参皂苷的心血管药理效应:进展与思考[J].中国科学:生命科学,2016,46(06):771-778.
28. 马林沁，张京春*, 刘 玥*.慢性间歇性低氧动物模型的比较[J].中国药理学通报,2016,32(04):445-450.
27. 赵莹科，张京春*, 刘 玥*,邬春晓,马林沁,张惠,吕长霞,雷舒雁.合并OSAS的高血压患者超敏C反应蛋白水平的Meta分析[J].中国循证心血管医学杂志,2016,8(02):144-149.
2015
26. 陈可冀，刘 玥. 中医药防治心肌梗死:思考与展望[J].医学研究杂志,2015,44(11):1-2.
25. 张惠，张京春*，刘 玥*,赵莹科,马林沁. 从肝论治冠心病的治法与方药研究进展[J].中西医结合心脑血管病杂志,2015,13(11):1281-1286.
24. 刘 玥，马晓昌，陈可冀. 心力衰竭防治领域的进展与思考[J].医学研究杂志,2015,44(08):6-8.
23. 陈可冀，刘 玥*. 多效药片与心血管疾病的预防:证据、评价与思考[J].中国循证医学杂志,2015,15(07):745-748.
22. 刘 玥，史大卓.中医临床方病对应关系的思考[J].中国中西医结合杂志,2015,35(07):882-885.
2014
21. 信琪琪，刘 玥*，杨琳，付长庚，陈可冀*.中药银杏制剂与糖尿病治疗:作用机制与临床应用[J].中国中药杂志,2014,39(23):4509-4515.
20. 郭明，刘 玥*，许琳，付长庚，陈可冀.中药银杏制剂的心血管药理效应:机制与展望[J].中国科学:生命科学,2014,44(06):543-550.
19. 陈可冀，刘 玥.素食与心血管健康:循证与思考[J].中国中西医结合杂志,2014,34(06):653-655.
18. 刘 玥，殷惠军，史大卓，陈可冀.活血化瘀中药与抗血小板治疗[J].科学通报,2014,59(08):647-655.
17. 陈可冀,刘 玥. 2013 ACC/AHA胆固醇治疗指南更新要点解读与思考[J].中国中西医结合杂志,2014,34(02):136-137.
2013
16. 刘 玥,陈可冀.瑜伽与心房颤动:Yoga My Heart研究的启示[J].中国中西医结合杂志,2013,33(09):1267-1268.
15. 刘 玥,史大卓.清宫药引的应用及其对现代临床遣方用药的启示[J].中医杂志,2013,54(18):1538-1541.
14. 刘 玥,殷惠军,陈可冀.血小板蛋白质组学及其在血瘀证与活血化瘀中药研究中的探索应用[J].中国科学:生命科学,2013,43(08):619-625.
13. 刘 玥,张京春,史大卓,陈可冀.波动性高血压与血小板活化及其中西医结合干预策略[J].中国中西医结合杂志,2013,33(07):869-872.
12. 陈可冀,刘 玥. 中美最新心血管病报告对比解读与思索[J].医学研究杂志,2013,42(07):1-2.
11. 陈可冀,刘 玥. 2013年中美国家心血管病报告要点对比解读及其启示[J].中国中西医结合杂志,2013,33(03):293-297.
10. 陈可冀,刘 玥. 临床医学本来就是整体[J].医学与哲学(A),2013,34(03):12-13.
9. 宋辉,刘 玥*. 心肾综合征及其中西医结合防治策略[J].医学研究杂志,2013,42(02):8-10.
8. 陈可冀,刘 玥*.高敏心肌肌钙蛋白的临床应用:优势与挑战[J].医学研究杂志,2013,42(02):1-3.
2012
7. 陈可冀,刘 玥. 2012年全球心肌梗死统一定义亮点解读[J].中国中西医结合杂志,2012,32(11):1445-1447.
6. 陈可冀,刘 玥.稳定性冠心病:PCI还是药物治疗的选择——一项新的Meta分析结果的启示[J].中国中西医结合杂志,2012,32(05):583-584.
5. 汪杰,刘 玥*,蒋跃绒.动脉粥样硬化及其中西医结合防治新策略[J].医学研究杂志,2012,41(05):9-11+117.
4. 刘 玥,谢鸣,张业.基于实验室指标动态变化的2型糖尿病胰岛素抵抗大鼠模型中医证候演变规律研究[J].中西医结合学报,2012,10(01):100-108.
2011
3. 刘 玥,谢鸣,张业.2型糖尿病胰岛素抵抗大鼠模型中医外观表征的变化[J].中国实验方剂学杂志,2011,17(14):127-131.
2. 刘 玥,蒋跃绒,殷惠军,陈可冀.凝溶胶蛋白与心血管疾病[J].中国分子心脏病学杂志,2011,11(01):50-53.
2007
1. 刘 玥,谢鸣.关于“以方测证”方法的思考[J].中医杂志,2007(05):459-461.
